Amphotericin: Difference between revisions

From WikiMD's Wellness Encyclopedia

CSV import
Tags: mobile edit mobile web edit
 
No edit summary
Line 1: Line 1:
{{Infobox drug
| name = Amphotericin B
| image = Amphotericin B structure.svg
| width = 250
| alt =
| caption = Chemical structure of Amphotericin B
| tradename = Fungizone, others
| Drugs.com =
| MedlinePlus = a682643
| pregnancy_AU = B3
| pregnancy_US = B
| legal_AU = S4
| legal_US = Rx-only
| routes_of_administration = Intravenous, topical
| bioavailability = Poorly absorbed orally
| protein_bound = 95%
| metabolism =
| elimination_half-life = 15 days
| excretion = Bile
| CAS_number = 1397-89-3
| ATC_prefix = J02
| ATC_suffix = AA01
| PubChem = 14956
| DrugBank = DB00681
| ChemSpiderID = 14236
| UNII = 7XU7A7DROE
| KEGG = D00203
| ChEBI = 28920
| ChEMBL = 417
| C=47
| H=73
| N=1
| O=17
| molecular_weight = 924.08 g/mol
}}
'''Amphotericin B''' is an [[antifungal]] medication used for serious fungal infections and leishmaniasis. It is often used for infections such as [[aspergillosis]], [[blastomycosis]], [[candidiasis]], [[coccidioidomycosis]], and [[cryptococcosis]].
'''Amphotericin B''' is an [[antifungal]] medication used for serious fungal infections and leishmaniasis. It is often used for infections such as [[aspergillosis]], [[blastomycosis]], [[candidiasis]], [[coccidioidomycosis]], and [[cryptococcosis]].


Line 56: Line 20:
* [[Fungal infection]]
* [[Fungal infection]]
* [[Liposomal amphotericin B]]
* [[Liposomal amphotericin B]]
== References ==
* {{cite journal |last1=Walsh |first1=Thomas J. |last2=Finberg |first2=Robert W. |title=Amphotericin B: Mechanism of Action and Resistance |journal=Clinical Infectious Diseases |volume=22 |issue=2 |year=1996 |pages=S97–S110 |doi=10.1093/clinids/22.Supplement_2.S97}}
* {{cite book |last=Kauffman |first=Carol A. |title=Fungal Infections: Diagnosis and Management |publisher=Springer |year=2006 |isbn=978-1-85233-905-8}}
== External Links ==
== External Links ==
* [https://www.drugs.com/monograph/amphotericin-b.html Drugs.com: Amphotericin B]
* [https://www.drugs.com/monograph/amphotericin-b.html Drugs.com: Amphotericin B]
* [https://www.mayoclinic.org/drugs-supplements/amphotericin-b-intravenous-route/description/drg-20061816 Mayo Clinic: Amphotericin B]
* [https://www.mayoclinic.org/drugs-supplements/amphotericin-b-intravenous-route/description/drg-20061816 Mayo Clinic: Amphotericin B]
[[Category:Antifungal agents]]
[[Category:Antifungal agents]]
[[Category:Polyenes]]
[[Category:Polyenes]]
[[Category:World Health Organization essential medicines]]
[[Category:World Health Organization essential medicines]]

Revision as of 12:51, 23 December 2024

Amphotericin B is an antifungal medication used for serious fungal infections and leishmaniasis. It is often used for infections such as aspergillosis, blastomycosis, candidiasis, coccidioidomycosis, and cryptococcosis.

Mechanism of Action

Amphotericin B works by binding to ergosterol, a key component of fungal cell membranes. This binding disrupts the membrane, causing cell contents to leak out, which ultimately leads to cell death. This mechanism is specific to fungi, as ergosterol is not found in human cell membranes.

Administration

Amphotericin B is typically administered intravenously due to its poor oral absorption. It is available in several formulations, including conventional amphotericin B deoxycholate and lipid formulations such as liposomal amphotericin B, which are designed to reduce toxicity.

Side Effects

Common side effects of amphotericin B include fever, chills, and headache. More serious side effects can include kidney damage, electrolyte imbalances, and infusion-related reactions. Lipid formulations are associated with fewer side effects compared to the conventional form.

Clinical Uses

Amphotericin B is used in the treatment of severe systemic fungal infections. It is often reserved for life-threatening infections due to its potential toxicity. It is also used in the treatment of certain protozoal infections, such as visceral leishmaniasis.

History

Amphotericin B was discovered in 1955 and was originally isolated from the bacterium Streptomyces nodosus. It has been a critical drug in the treatment of fungal infections for decades, despite its side effects.

See Also

External Links